Results 1 to 10 of about 792,259 (266)
Diffuse alveolar haemorrhage (DAH) is a rapidly developing condition owing to a lack of effective treatment and resulting in a high mortality rate in systemic lupus erythematosus (SLE).
Xinai Han +10 more
doaj +1 more source
This study was aimed to compare hemostatic, fibrinolytic and thrombotic parameters in pre and post induction chemotherapy in acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL).
Tehmina Nafees Sonia Khan +5 more
doaj +1 more source
Background Classical MPNs including ET and PMF have a chronic course and potential for leukaemic transformation. Timely diagnosis is obligatory to ensure appropriate management and positive outcomes.
Uzma Zaidi +9 more
doaj +1 more source
Background Osteogenesis imperfecta (OI) causes a number of abnormalities in somatic development. The predominant symptoms are reduced bone mass and an increased risk of fractures as well as bone deformities and short stature.
E. Jakubowska-Pietkiewicz +4 more
doaj +1 more source
Microbiota-bone axis in ageing-related bone diseases [PDF]
Wang Yicheng, Liu Xiaonan
exaly +2 more sources
Purpose. GWAS has successfully located and analyzed the pathogenic genes of osteoporosis. Genetic studies have found that heritability of BMD is 50%–85% while the other half is caused by hip geometric parameters and tissue horizontal characteristics ...
Weiwei Hu +8 more
doaj +1 more source
In 2008, the Centre Hospitalier Universitaire Vaudois (CHUV, Lausanne, Switzerland) initiated a Fracture Liaison Service (FLS). All patients hospitalised for a low trauma fracture are identified by the FLS.
Bérengère Aubry-Rozier +7 more
doaj +1 more source
Introduction This study aimed to investigate the relationship of gene polymorphisms and fat mass (FM) in Chinese population. Material and methods Healthy males, premenopausal and postmenopausal women were recruited. Single Nucleotide Polymorphisms (SNPs)
Luyue Qi, Zhenlin Zhang, Weiwei Hu
doaj +1 more source
Advance in the application of organoids in bone diseases [PDF]
Kong Y +5 more
exaly +2 more sources
Background Myelodysplastic syndromes (MDS) are heterogeneous group of haematopoietic stem cell disorders and have variable reduction in the production of red cells, platelets and mature granulocytes.
Nida Anwar +5 more
doaj +1 more source

